Volastra Therapeutics

Bicara Therapeutics

This biotechnology company develops dual-action biologics to treat patients with solid tumours by targeting the tumour microenvironment.

Tango Therapeutics

This biotechnology company develops precision oncology medicines targeting genetic vulnerabilities in cancer cells for patients with solid tumours.

Avenzo Therapeutics

This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.

Enedra Therapeutics Ltd

This company develops precision medicines and biomarkers to treat advanced, genetically heterogeneous cancers for patients with drug-resistant tumours.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.

Istari Oncology

This clinical-stage biotechnology company develops immuno-oncology platforms and immunotherapies to treat patients with glioblastoma and other solid tumours.

Xilio Therapeutics

This biotechnology company develops tumour-activated immuno-oncology therapies designed to treat patients with solid cancers while reducing systemic side effects.

Akamis Bio

This clinical-stage oncology company develops intravenously administered immunotherapies to treat solid tumours, specifically targeting patients living with colorectal cancer.